Astellas Pharma reported JPY263.02B in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Astellas Pharma 4503:JP Y 263018M 894M
Chugai Pharma 4519:JP Y 183070M 29718M
Daiichi Sankyo 4568:JP Y 178489M 428M
Eisai 4523:JP Y 122837M 36807M
Kyowa Hakko Kirin 4151:JP Y 66088M 1038M
M3 2413:JP 29.05B 754M
Otsuka Holdings 4578:JP Y 265142M 8350M
Shionogi 4507:JP Y 61467M 4833M
Sumitomo Dainippon 4506:JP Y 124156M 31436M
Takeda 4502:JP Y 569023M 139316M
Terumo 4543:JP Y 91985M 2274M